211 related articles for article (PubMed ID: 17377984)
21. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
Nakazawa G; Vorpahl M; Finn AV; Narula J; Virmani R
JACC Cardiovasc Imaging; 2009 May; 2(5):625-8. PubMed ID: 19442951
[No Abstract] [Full Text] [Related]
22. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
[TBL] [Abstract][Full Text] [Related]
23. Direct stenting in the DES era: Can we do better?
Bass TA
Catheter Cardiovasc Interv; 2007 Oct; 70(4):513-4. PubMed ID: 17896409
[No Abstract] [Full Text] [Related]
24. Better results with the new generation bare metal stents.
Vik-Mo H
Scand Cardiovasc J; 2009 Apr; 43(2):84-6. PubMed ID: 19117238
[No Abstract] [Full Text] [Related]
25. Percutaneous UPLM revascularisation: the time has come.
Goyal BK
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1050. PubMed ID: 20517967
[No Abstract] [Full Text] [Related]
26. Optimal stent expansion and complete neointimal coverage: does this association make sense?
Mintz GS; Choi SY
JACC Cardiovasc Interv; 2009 Oct; 2(10):995-6. PubMed ID: 19850261
[No Abstract] [Full Text] [Related]
27. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
28. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
29. NEVO™: a new generation of sirolimus-eluting coronary stent.
Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
[No Abstract] [Full Text] [Related]
30. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
Fanggiday JC; Stella PR; Guyomi SH; Doevendans PA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):629-35. PubMed ID: 18360855
[TBL] [Abstract][Full Text] [Related]
32. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
[TBL] [Abstract][Full Text] [Related]
34. Another small step for small vessels.
Morrison DA
Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
[No Abstract] [Full Text] [Related]
35. Nevo stent: a successful stent makeover.
Belardi JA
Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
[No Abstract] [Full Text] [Related]
36. If I've heard it once, I've heard it (not yet) a hundred times.
Butman SM
Catheter Cardiovasc Interv; 2011 Mar; 77(4):502. PubMed ID: 21351224
[No Abstract] [Full Text] [Related]
37. Drug-eluting stent endothelium: presence or dysfunction.
van Beusekom HM; Serruys PW
JACC Cardiovasc Interv; 2010 Jan; 3(1):76-7. PubMed ID: 20129573
[No Abstract] [Full Text] [Related]
38. First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial.
Ribeiro EE; Campos CM; Ribeiro HB; Lopes AC; Esper RB; Meirelles GX; Perin MA; Abizaid A; Lemos PA
EuroIntervention; 2014; 9(12):1380-4. PubMed ID: 24755382
[TBL] [Abstract][Full Text] [Related]
39. A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries.
Jabara R; Geva S; Ribeiro HB; Chen JP; Hou D; Li J; King SB; Chronos N; Robinson KA
EuroIntervention; 2009 Nov; 5(5):619-26. PubMed ID: 20142184
[TBL] [Abstract][Full Text] [Related]
40. The current status of stent placement in small coronary arteries < 3.0 mm in diameter.
Lau KW; Hung JS; Sigwart U
J Invasive Cardiol; 2004 Aug; 16(8):411-6. PubMed ID: 15282416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
